Phoenux AG was founded in 2005 by Kerstin Hammer, a Swiss lawyer.
Business purpose is the development of new medications for the drug substitution market. Private investors made research and development in this sector possible and successful.
Since spring of 2006, Dr. Lars Hermann is the scientific head of the company.
Dr. Hermann had been working as a medical doctor in this indication. Patients and authorities are desiring a new substitution medication, meeting their needs. Dr. Hermann experienced this indication as a promising market for a new medication.
In Europe, 650.000 patients are receiving a once-daily substitution medication for heroin dependency. Only few medications are available. Therefore, new medications are in high demand from many sides.
Phoenux AG wants to offer the patients a reliable medication. The patients should be respected and their needs accepted. Until now this patient group was often neglected. Their disease is still today often regarded as a deficiency of character. The new medication was developed based on the needs of the patients. The anti-abuse system as well as the galenic formulation were developed in extensive optimization and carefully executed studies with high scientific claim.
The set-up of the company is slim. Phoenux is mostly working with highly competent consultants in their field of expertise. The company is situated in a tax-friendly Canton in Switzerland, the Canton of Schwyz.
The small town of Schindellegi / Feusisberg was voted by the Swiss magazine “Weltwoche” as Switzerland’s most attractive community.
Dr. Lars Hermann
Medical Doctor, Scientific and Medical Management
Mrs. Kerstin Hammer
Lawyer, Administrative and Financial Management
Phoenux is interested in finding partners from the industry. If you are interested, please contact us.